Chong Qiu | Nanomedicine | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. Chong Qiu | Artificial Intelligence | Young Scientist Award

Associate Professor at China Academy of Chinese Medical Sciences, China

Dr. Chong Qiu is an Associate Professor at the Artemisinin Research Center and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences. He earned his PhD from Peking University, specializing in nanocarriers for drug delivery, siRNA, and peptide therapeutics. Dr. Qiuā€™s research focuses on innovative nanoparticle-based drug delivery systems, with applications in cancer treatment, pulmonary fibrosis, and targeted gene therapies. His work is widely recognized, with numerous high-impact publications in prestigious journals like Nature Communications and Journal of Nanobiotechnology. He is also a board member of several scientific journals and a leading expert in his field.

Publication profile

Education:

  • PhD in Pharmaceutical Science, Peking University, 2019
  • Bachelorā€™s degree, Peking University, 2014

Research Interests:

  • Nanocarriers for siRNA delivery
  • Nano-carriers for oral protein and peptide
  • Targeted nanoparticulate drug delivery

Professional Roles:

  • Young Scientist Board Member for Asian Journal of Pharmaceutical Sciences, iMeta, and Traditional Medicine Research and Exploration

Publication

  1. Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum
    Journal: iMeta
    Year: 2024
    DOI: 10.1002/IMT2.176
    Contributors: Gao, Peng; Wang, Jianyou; Qiu, Chong; Zhang, Huimin; Wang, Chen; Zhang, Ying; Sun, Peng; Chen, Honglin; Wong, Yin Kwan; Chen, Jiayun et al.

 

  1. Enhanced tumor penetration across the blood-brain barrier: endoplasmic reticulum membrane hybrid siRNA nanoplexes
    Journal: Materials Today Nano
    Year: 2024
    DOI: 10.1016/j.mtnano.2023.100442
    Contributors: Chong Qiu; Shun Tao Liang; Qing Chao Tu; Chen Pan; Jia Yin Han; Bo Wu; Qiu Yan Guo; Yu Qian Lu; Jun Zhe Zhang; Yu Qing Meng et al.

 

  1. Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
    Journal: Research
    Year: 2023
    DOI: 10.34133/RESEARCH.0148
    Contributors: Qiu, Chong; Xia, Fei; Zhang, Junzhe; Shi, Qiaoli; Meng, Yuqing; Wang, Chen; Pang, Huanhuan; Gu, Liwei; Xu, Chengchao; Guo, Qiuyan et al.

 

  1. Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy
    Journal: International Journal of Biological Sciences
    Year: 2023
    DOI: 10.7150/ijbs.79328
    Contributors: Chong Qiu; Yanyan Wu; Qiaoli Shi; Qiuyan Guo; Junzhe Zhang; Yuqing Meng; Chen Wang; Fei Xia; Jigang Wang; Chengchao Xu

 

  1. Anemoside B4 alleviates neuropathic pain through inhibiting inflammation
    Source: ResearchSquare
    Year: 2022
    DOI: 10.21203/rs.3.rs-1821028
    Contributors: Zhao, M.; Li, H.; Yang, T.; Qiu, C.; Lu, T.; Wang, Q.; Guo, Q.; Wang, J.

 

  1. Preparation and application of calcium phosphate nanocarriers in drug delivery
    Journal: Materials Today Bio
    Year: 2022
    DOI: 10.1016/j.mtbio.2022.100501
    Contributors: Chong Qiu; Yanyan Wu; Qiuyan Guo; Qiaoli Shi; Junzhe Zhang; Yuqing Meng; Fei Xia; Jigang Wang

 

šŸ† Conclusion

Dr. Chong Qiu is highly suitable for a Young Scientist Award. His innovative research, strong publication record, and leadership roles in the field of nanotechnology-based drug delivery make him a compelling candidate. With some strategic improvements in expanding research impact and fostering international collaborations, he has the potential to significantly advance the scientific community’s understanding of targeted therapeutics.